Recombinant factor XIII reduces severe pleural effusion in children after open-heart surgery

Pediatric Cardiology

Volumn 27, Issue 1, 2006, Pages 56-60

  Schroth, M ^a   Meissner U ^a   Cesnjevar, R ^a   Weyand, M ^a   Singer, H ^a   Rascher, W ^a   Klinge, J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Chylous; Human factor XIII; Open Heart surgery; Pleural effusion

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 13;

ARTICLE; CHILDHOOD; CHYLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEHYDRATION; DISEASE COURSE; DRAIN; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; EVALUATION; GROUPS BY AGE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; OPEN HEART SURGERY; PARAMETERS OF MEASUREMENT AND ANALYSIS; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TUBE; WEIGHT; CASE CONTROL STUDY; CHILD; CHYLOTHORAX; CONGENITAL HEART MALFORMATION; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; INFANT; LENGTH OF STAY; MALE; PRESCHOOL CHILD; STATISTICS; TREATMENT OUTCOME; WOUND HEALING;

CASE-CONTROL STUDIES; CHEST TUBES; CHILD; CHILD, PRESCHOOL; CHYLOTHORAX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FACTOR XIII; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; LENGTH OF STAY; MALE; PLEURAL EFFUSION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS; TREATMENT OUTCOME; WOUND HEALING;

EID: 33644748490     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-0993-5     Document Type: Article

References (29)

1. Akaogi E, Mitsui K, Sohara Y, et al. (1989) Treatment of postoperative chylothorax with intrapleural fibrin glue. Ann Thorac Surg 48:116-118
2. Albala DM (2003) Fibrin sealants in clinical practice. Ciovasc Surg 11 (Suppl 1):5-11
3. Canonico S (2003) The use of human fibrin glue in the surgical operations. Acta Biomed Ateneo Parmense 74 (Suppl 2):21-25
4. Carlo E Goebell H, Dignass AU (1999) Factor XIII modulates intestinal epithelial wound healing in vitro. Scand J Gastroenterol 34:485-490
5. Chamouard P, Grunebaum L, Wiesel ML, et al. (1998) Significance of diminished factor XIII in Crohn's disease. Am J Gastroenterol 93:610-614
6. Dardik R, Solomon A, Loscalzo J, et al. (2003) Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol 3:1472-1477
7. Dunn CJ, Goa KL (1999) Fibrin sealant: a review of its use in surgery and endoscopy. Drugs 58:863-886
8. Egbring R, Kroniger A, Seitz R (1996) Factor XIII deficiency: pathogenic mechanisms and clinical significance. Semin Thromb Hemost 22:419-425
9. Flori HR, Johnson LD, Hanley FL, Fineman JR (2000) Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: associated complications and outcomes. Crit Care Med 28:2997-3001
10. Hillerdal G (1997) Chylothorax and pseudochylothorax. Eur Respir J 10:1157-1162
11. Ichinose A (2001) Physiopathology and regulation of factor XIII. Thromb Haemost 86:57-65
12. Karges HE, Clemens R (1988) Factor XIII: enzymatic and clinical aspects. Behring Inst Mitt:143-58
13. Lancey RA, Gaca C, Yander Salm TJ (2001) The use of smaller, more flexible chest drains following open heart surgery: an initial evaluation. Chest 119:19-24
14. Le Pimpec-Barthes F, D'Attellis N, Dujon A, Legman P, Riquet M (2002) Chylothorax complicating pulmonary resection. Ann Thorac Surg 73:1714-1719
15. Linskens RK, van Bodegraven AA, Schoorl M, Tuynman HA, Bartels P (2001) Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci 46:644-648
16. Lorand L (1950) Fibrin clots. Nature 166:694-695
17. Lorand L (2001) Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci 936:291-311
18. Lorenz R, Born P, Olbert P, Classen M (1995) Factor XIII substitution in ulcerative colitis. Lancet 345:449-450
19. Lorenz R, Olbert P, Born P (1996) Factor XIII in chronic inflammatory bowel diseases. Semin Thromb Hemost 22:451-455
20. Meizner I, Carmi R, Bar-Ziv J (1986) Congenital chylothorax-prenatal ultrasonic diagnosis and successful postpartum management. Prenat Diagn 6:217-221
21. Menzebach A, Cassens U, Van Aken H, Booke M (2003) Strategies to reduce perioperative blood loss related to non-surgical bleeding. Eur J Anaesthesiol 20:764-770
22. Noll T, Wozniak G, McCarson K, et al. (1999) Effect of factor XIII on endothelial barrier function. J Exp Med 189:1373-1382
23. Phillips M, Dickneite G, Metzner H (2003) Fibrin sealants in supporting surgical techniques: strength in factor XIII. Cardiovasc Surg 11 (Suppl 1):13-16
24. Pihusch R, Salat C, Gohring P, et al. (2002) Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut..Br J Haematol 117:469-476
25. Platz A, Simmen HP, Heinzelmann M, Kohler A, Trentz O (1995) Chylothorax after blunt thoracic trauma. Chirurg 66:127-130
26. Vaynblat M, Chiavarelli M, Anderson JE, et al. (1997) Pleural drainage after repair of tetralogy of Fallot. J Card Surg 12:71-76
27. Wozniak G (2003) Fibrin sealants in supporting surgical techniques: the importance of individual components. Cardiovasc Surg 11 (Suppl 1):17-21
28. Zamboni P, De Mattel M, Ongaro A, et al. (2004) Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells. Vasc Endovascular Surg 38:431-438
29. Zocchi L (2002) Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 20:1545-1558